首页> Frontiers in oncology> Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.

Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Monica,Celli

第一单位： Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Forlì-Cesena, Italy.

作者： Monica,Celli ^[1] ; Roberta,Gunelli ^[2] ; Fabio,Ferroni ^[3] ; Matteo,Costantini ^[4] ; Domenico,Barone ^[3] ; Lorenzo,Fantini ^[1] ; Eugenia,Fragalà ^[2] ; Irene,Marini ^[1] ; Valentina,Di Iorio ^[5] ; Flavia,Foca ^[6] ; Manuela,Monti ^[6] ; Federica,Matteucci ^[1] ; Paola,Caroli ^[1]

作者单位： Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Forlì-Cesena, Italy. ^[1] Department of Urology, AUSL Romagna, Morgagni-Pierantoni Hospital, Forlì, Forlì-Cesena, Italy. ^[2] Radiology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Forlì-Cesena, Italy. ^[3] Department of Pathology, AUSL Romagna, Morgagni-Pierantoni Hospital, Forlì, Forlì-Cesena, Italy. ^[4] Radiopharmacy, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Forlì-Cesena, Italy. ^[5] Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Forlì-Cesena, Italy. ^[6]

关键词 ISUP grade group PSMA PET biopsy guidance clinically significant prostate cancer (csPCa)imaging biomarkers lesion targeting multiparametric MRI (mpMRI)prostate cancer

DOI 10.3389/fonc.2025.1720861

PMID 41561764

发布时间 2026-01-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交